Highest-materiality recent filing
Merger consideration: each LPSN share converted into a formula-driven number of SoundHound shares; SoundHound stock price collared at $7-$12.
LivePerson Q4 revenue $59.3M beats guidance; net loss narrows to $46.1M from $112.1M YoY
Total revenue $59.3M, down 19% YoY, but above high end of guidance.
LivePerson Q3 revenue $60.2M, down 19% YoY; net income $8.7M on debt restructuring gain
Revenue $60.2M, down 19% YoY; above high end of guidance.
LivePerson to effect 1-for-15 reverse stock split on Oct 13, 2025
Reverse stock split ratio of 1-for-15 effective before market open on October 13, 2025.
Exchanged $341.1M of 2026 convertible notes for $45M cash, $115M new 10% secured notes due 2029, 53.3M common shares, and 26,551 Series B preferred shares.
LivePerson reports Q2 revenue $59.6M, net loss $15.7M, debt refinancing cuts $226M
Total revenue $59.6M, down 25.4% YoY, at high-end of guidance; adjusted EBITDA $2.9M above high-end.
Exchange of $341.1M of 0% convertible notes with $45M cash, $115M of 10% secured notes due Dec 2029, and common/preferred equity totaling 39% of fully diluted shares.
LivePerson Q1 revenue $64.7M (-24% YoY), net loss narrows to $14.1M, beats guidance
Revenue $64.7M, down 24% YoY, but above midpoint of guidance range.
LivePerson receives Nasdaq notice for bid price below $1.00; 180 days to regain compliance
Nasdaq notified LivePerson on May 1, 2025 that closing bid price was below $1.00 for 30 consecutive business days.
LivePerson Q4 revenue $73.2M, down 23.3% YoY; net loss widens to $112.1M
Total revenue $73.2M, above high-end of guidance; down 23.3% YoY on customer cancellations and downsells.
LivePerson CPTO Alex Kroman to depart Dec 31, 2024; external successor search
Chief Product & Technology Officer Alex Kroman leaving effective December 31, 2024.
LivePerson Q3 revenue $74.2M (down 27% YoY), net loss $28.3M; guidance beat
Total revenue $74.2M, down 26.7% YoY; above high-end of guidance.
Cooperates with Vector Capital (~12% owner): standstill, voting commitments, board refreshment.
LivePerson Q2 revenue $79.9M (-18% YoY), net income $41.8M; beats guidance
Total revenue $79.9M, down 18.1% YoY; at high-end of guidance range.
LivePerson completes $150M debt exchange with Lynrock, issues secured notes and warrants
Exchanged $145.957M of 0% 2026 notes for $100M of new First Lien Convertible Notes due 2029 plus $50M in new cash.
LivePerson receives Nasdaq delisting notice for bid price below $1.00
Nasdaq notified LivePerson on May 10, 2024 that its stock closed below $1.00 for 30 consecutive business days.
Exchange of $145.96M 2026 convertible notes for $100M new 2029 senior secured notes reduces debt by ~$46M.
LivePerson Q1 revenue $85.1M, down 21% YoY; net loss widens to $35.6M
Total revenue of $85.1M, above high-end of guidance, down 20.9% YoY due to churn and exited lines.
LivePerson Q4 revenue $95.5M, above guidance; adjusted EBITDA $3.7M vs -$5.2M YoY
Revenue $95.5M, down 22.1% YoY, but above midpoint of guidance; net loss $40.5M ($0.48 per share).
LivePerson adopts poison pill to protect $400M+ NOLs after stockholder accumulates >10% stake
Cumulative NOLs exceed $400M as of Dec 31, 2023; plan aims to preserve these tax assets.
LivePerson appoints John Sabino as CEO, effective Jan. 10; Collins expands role to CFO/COO
New CEO John Sabino appointed effective Jan. 10, 2024; also appointed to the Board.
LivePerson Q3 revenue $101.3M, down 22% YoY; net loss $53.3M, adj EBITDA $10.6M
Total revenue $101.3M, at top end of guidance, down 21.8% YoY from $129.5M.
LivePerson Q2 revenue $97.5M (down 26% YoY), net income $10.8M vs loss, adj EBITDA $12.8M
Revenue $97.5M, down 26.4% YoY; net income $10.8M ($0.14/sh) vs net loss $75.4M ($0.98 loss) in Q2 2022.
LivePerson CEO Robert LoCascio steps down; CFO John Collins named interim CEO
Robert LoCascio resigned as CEO and board member effective Aug 7, 2023; will serve as Special Advisor through Dec 31, 2023.
LivePerson founder/CEO Robert LoCascio to step down Dec 31, 2023; Jill Layfield named Board Chair
LoCascio's employment agreement will not be renewed; departure effective December 31, 2023.
LivePerson amends WildHealth earnout; pays $12M cash, eliminates up to $120M stock earnout
LivePerson and WildHealth sellers amended merger agreement; earnout terms replaced with $12M cash payment (paid May 31, 2023) and contingent sale payment up to $23M.
LivePerson Q1 revenue $107.7M (-17% YoY), net loss narrows to $17.4M; repurchased 68% of 2024 notes
Revenue $107.7M (-17% YoY); net loss $17.4M ($0.23/share) vs $65.4M loss a year ago.
LivePerson repurchases $157.5M of 0.75% convertible notes for $149.7M cash (95% of par)
Repurchased $157.5M aggregate principal of its 0.750% Convertible Senior Notes due 2024.
On January 14, 2025, Mr. Bruce Hansen gave notice of his intention to resign from the Board of Directors (the “Board”) of LivePerson, Inc. (the “Company”), effective January 31, 2025.
Mr. James Miller, a current director and Chair of the Board’s Nominating and Corporate Governance Committee, will become the Chair of the Board.
On November 27, 2024, LivePerson, Inc. (the “Company”) announced that its Chief Product & Technology Officer, Alex Kroman, has decided to depart from the Company, effective December 31, 2024.
On October 23, 2024, Yael Zheng informed the Board of her intent to voluntarily resign from her positions as a director of the Company and member of the Board’s Audit Committee and Compensation Committees, effective as of the date of the 2024 Annual Meeting.
John Collins, the Company’s Chief Financial Officer (principal financial officer), who has been serving as the Company’s Interim Chief Executive Officer and principal executive officer since August 8, 2023, will continue to serve as the Company’s Chief Financial Officer and has been appointed by the Board to serve also as the Company’s Chief Operating Officer.
On January 9, 2024, LivePerson, Inc. (the “ Company ”) announced that the Board of Directors of the Company (the “ Board ”) has appointed Anthony John Sabino to serve as Chief Executive Officer (principal executive officer) of the Company after a search process conducted by a search committee comprised of independent directors.
Mr. Sabino has also been appointed as a director of the Company.
On September 7, 2023, the Board of Directors (the “Board”) of LivePerson, Inc. (the “Company”) appointed Jeffrey Ford as the Company’s principal accounting officer.
Effective concurrently with Mr. Ford’s designation as the Company’s principal accounting officer, the designation of Mr. John Collins in that capacity ended.
On August 7, 2023, Mr. LoCascio resigned from the Company’s Board of Directors (the "Board"), concurrent with the cessation of his service as Chief Executive Officer
On August 7, 2023, John Collins was appointed as Interim Chief Executive Officer and principal executive officer of the Company, effective immediately.
Mr. LoCascio has assumed the role of Special Advisor through December 31, 2023 and shall no longer serve as Chief Executive Officer of the Company, effective August 7, 2023.
Max materiality 0.90 · Median 0.60 · Most common event other_material